188 related articles for article (PubMed ID: 21044770)
1. Proteomic discovery of diabetic nephropathy biomarkers.
Merchant ML; Klein JB
Adv Chronic Kidney Dis; 2010 Nov; 17(6):480-6. PubMed ID: 21044770
[TBL] [Abstract][Full Text] [Related]
2. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
3. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
[TBL] [Abstract][Full Text] [Related]
4. Advances in early biomarkers of diabetic nephropathy.
Zhang J; Liu J; Qin X
Rev Assoc Med Bras (1992); 2018 Jan; 64(1):85-92. PubMed ID: 29561946
[TBL] [Abstract][Full Text] [Related]
5. Diabetic Nephropathy - possibilities of early laboratory diagnostics and course prediction (review of literature).
Popykhova EB; Ivanov AN; Stepanova TV; Lagutina DD; Savkina AA
Klin Lab Diagn; 2021 Oct; 66(10):593-602. PubMed ID: 34665945
[TBL] [Abstract][Full Text] [Related]
6. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
[TBL] [Abstract][Full Text] [Related]
7. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
8. Histological Spectrum of Clinical Kidney Disease in Type 2 Diabetes Mellitus Patients with special Reference to nonalbuminuric Diabetic Nephropathy: A Kidney Biopsy-based Study.
Prakash J; Patel PS; Iqbal M; Sharma SS; Singh S; Agrawal NK; Singh U
J Assoc Physicians India; 2022 Aug; 70(8):11-12. PubMed ID: 36082725
[TBL] [Abstract][Full Text] [Related]
9. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
10. Study of diabetic nephropathy in the proteomic era.
Thongboonkerd V
Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
[TBL] [Abstract][Full Text] [Related]
11. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
Betz BB; Jenks SJ; Cronshaw AD; Lamont DJ; Cairns C; Manning JR; Goddard J; Webb DJ; Mullins JJ; Hughes J; McLachlan S; Strachan MWJ; Price JF; Conway BR
Kidney Int; 2016 May; 89(5):1125-1135. PubMed ID: 27083286
[TBL] [Abstract][Full Text] [Related]
12. Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?
Papale M; Di Paolo S; Vocino G; Rocchetti MT; Gesualdo L
J Nephrol; 2014 Jun; 27(3):221-8. PubMed ID: 24567069
[TBL] [Abstract][Full Text] [Related]
13. [Dynamics of diabetic nephropathy and other complications of type I diabetes mellitus in the period of 1996-2002 (data from 2 Kaunas outpatient polyclinics)].
Bumblyte IA; Pakalnyte R; Radzeviciene L; Sepetauskiene E; Gaupsiene E; Kavaliauskiene J
Medicina (Kaunas); 2003; 39 Suppl 1():51-8. PubMed ID: 12761421
[TBL] [Abstract][Full Text] [Related]
14. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients.
Darmayanti S; Lesmana R; Meiliana A; Abdulah R
Curr Diabetes Rev; 2021; 17(6):e123120189796. PubMed ID: 33393899
[TBL] [Abstract][Full Text] [Related]
15. When to perform renal biopsy in patients with type2 diabetes mellitus? Predictive model of non-diabetic renal disease.
García-Martín F; González Monte E; Hernández Martínez E; Bada Boch T; Bustamante Jiménez NE; Praga Terente M
Nefrologia (Engl Ed); 2020; 40(2):180-189. PubMed ID: 31761446
[TBL] [Abstract][Full Text] [Related]
16. Insights into predicting diabetic nephropathy using urinary biomarkers.
Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
[TBL] [Abstract][Full Text] [Related]
17. Urinary proteomics for early diagnosis in diabetic nephropathy.
Zürbig P; Jerums G; Hovind P; Macisaac RJ; Mischak H; Nielsen SE; Panagiotopoulos S; Persson F; Rossing P
Diabetes; 2012 Dec; 61(12):3304-13. PubMed ID: 22872235
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics.
Ding X; Zhang D; Ren Q; Hu Y; Wang J; Hao J; Wang H; Zhao X; Wang X; Song C; Du J; Yang F; Zhu H
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686366
[TBL] [Abstract][Full Text] [Related]
19. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy.
Zhao L; Zhang Y; Liu F; Yang H; Zhong Y; Wang Y; Li S; Su Q; Tang L; Bai L; Ren H; Zou Y; Wang S; Zheng S; Xu H; Li L; Zhang J; Chai Z; Cooper ME; Tong N
J Endocrinol Invest; 2021 Dec; 44(12):2709-2723. PubMed ID: 34043214
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
